[Clinical features and viral markers in patients with chronic hepatitis positive for both HBs antigen and anti-C-100 antibody]. 1991

K Chayama, and Y Arase, and S Saito, and K Ikeda, and H Kumada, and T Matsumoto, and M Kobayashi, and Y Sakai, and T Morinaga
Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan.

Among 612 patients with chronic hepatitis type B, 24 patients tested positive for anti-C-100 antibody. Clinical features and viral markers of these 24 patients were studied. Anti-C-100 antibody was detected more often in patients negative for HBe antigen than those positive for this antigen (22/385 vs. 2/227 [P less than 0.01]). HCV RNA, as detected by reverse transcription and nested polymerase chain reaction, was positive in 20 of 22 patients negative for HBe antigen whereas it was detected in only one of two patients positive for HBe antigen. In a patient who seroconverted from HBe antigen to anti-HBe HCV RNA was undetectable in the HBe antigen positive phase and had become detectable after seroconversion. These data indicate that both hepatitis virus (type B and type C) can co-infect in a patient and that type C becomes active after the seroconversion from HBe antigen to anti-HBe.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D005260 Female Females
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Chayama, and Y Arase, and S Saito, and K Ikeda, and H Kumada, and T Matsumoto, and M Kobayashi, and Y Sakai, and T Morinaga
January 1980, Scandinavian journal of gastroenterology,
K Chayama, and Y Arase, and S Saito, and K Ikeda, and H Kumada, and T Matsumoto, and M Kobayashi, and Y Sakai, and T Morinaga
April 1984, Fortschritte der Medizin,
K Chayama, and Y Arase, and S Saito, and K Ikeda, and H Kumada, and T Matsumoto, and M Kobayashi, and Y Sakai, and T Morinaga
January 2009, Pathologie-biologie,
K Chayama, and Y Arase, and S Saito, and K Ikeda, and H Kumada, and T Matsumoto, and M Kobayashi, and Y Sakai, and T Morinaga
January 1978, Egyptian journal of bilharziasis,
K Chayama, and Y Arase, and S Saito, and K Ikeda, and H Kumada, and T Matsumoto, and M Kobayashi, and Y Sakai, and T Morinaga
February 1984, Gastroenterologie clinique et biologique,
K Chayama, and Y Arase, and S Saito, and K Ikeda, and H Kumada, and T Matsumoto, and M Kobayashi, and Y Sakai, and T Morinaga
August 2004, Nihon rinsho. Japanese journal of clinical medicine,
K Chayama, and Y Arase, and S Saito, and K Ikeda, and H Kumada, and T Matsumoto, and M Kobayashi, and Y Sakai, and T Morinaga
April 1976, Deutsche medizinische Wochenschrift (1946),
K Chayama, and Y Arase, and S Saito, and K Ikeda, and H Kumada, and T Matsumoto, and M Kobayashi, and Y Sakai, and T Morinaga
November 1978, Medical microbiology and immunology,
K Chayama, and Y Arase, and S Saito, and K Ikeda, and H Kumada, and T Matsumoto, and M Kobayashi, and Y Sakai, and T Morinaga
January 1977, Giornale di batteriologia, virologia ed immunologia,
K Chayama, and Y Arase, and S Saito, and K Ikeda, and H Kumada, and T Matsumoto, and M Kobayashi, and Y Sakai, and T Morinaga
November 1976, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!